Double maintains 4 strategies that include SRPT - Sarepta Therapeutics, Inc.
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| SATS | -19.59% | $8.87B | +57.45% | 0.00% |
| CARV | -17.34% | $9.29M | +17.31% | 0.00% |
| AIFU | -16.13% | $17.04M | +83.91% | 0.00% |
| ULS | -12.88% | $14.32B | +63.07% | 0.71% |
| SAGE | -11.16% | $580.51M | -21.17% | 0.00% |
| FARO | -10.97% | $848.78M | +156.21% | 0.00% |
| HRTG | -9.90% | $653.34M | +202.01% | 0.00% |
| ILPT | -9.74% | $365.10M | +37.31% | 0.70% |
| DRD | -9.40% | $1.17B | +41.04% | 2.03% |
| MKTX | -9.00% | $8.10B | +1.50% | 1.39% |
| VRA | -8.78% | $65.36M | -63.94% | 0.00% |
| PRA | -8.07% | $1.22B | +109.87% | 0.00% |
| OSCR | -7.78% | $3.66B | -12.95% | 0.00% |
| MVO | -7.73% | $68.54M | -39.92% | 21.06% |
| EVGO | -7.32% | $462.88M | -13.75% | 0.00% |
| CTLP | -7.03% | $807.15M | +67.73% | 0.00% |
| LITB | -6.73% | $24.09M | -72.65% | 0.00% |
| FINV | -6.67% | $1.48B | +111.16% | 2.59% |
| TME | -6.54% | $13.85B | +30.80% | 0.89% |
| CRCT | -6.29% | $1.12B | +0.26% | 3.77% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| IPI | <0.01% | $467.42M | +42.97% | 0.00% |
| NRDS | 0.01% | $789.09M | -27.17% | 0.00% |
| CDRE | 0.02% | $1.33B | -10.98% | 1.11% |
| BTCT | -0.03% | $31.95M | +108.85% | 0.00% |
| SOL | -0.04% | $98.02M | +6.70% | 0.00% |
| ALAR | -0.05% | $85.80M | -59.40% | 0.00% |
| CRMD | 0.05% | $835.10M | +134.73% | 0.00% |
| CTRI | -0.06% | $1.86B | +9.40% | 0.00% |
| TKC | -0.07% | $5.07B | -28.85% | 5.48% |
| KMB | -0.08% | $42.93B | -8.58% | 3.86% |
| TU | -0.12% | $25.13B | +6.05% | 6.96% |
| CELH | 0.12% | $11.63B | -23.45% | 0.00% |
| EHTH | -0.13% | $117.97M | -17.58% | 0.00% |
| SHEN | 0.19% | $810.79M | -17.43% | 0.66% |
| K | -0.25% | $27.56B | +40.50% | 2.87% |
| YALA | -0.29% | $988.02M | +57.66% | 0.00% |
| AVDX | -0.29% | $2.03B | -20.15% | 0.00% |
| BTU | 0.30% | $1.85B | -33.67% | 1.97% |
| GALT | 0.33% | $158.86M | +12.05% | 0.00% |
| FIGS | 0.36% | $975.31M | +4.53% | 0.00% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| BEAM | 39.21% | $2.13B | -21.28% | 0.00% |
| ARWR | 39.11% | $2.53B | -34.86% | 0.00% |
| RNA | 37.53% | $3.79B | -29.80% | 0.00% |
| SNDX | 37.27% | $825.20M | -59.16% | 0.00% |
| KRYS | 37.11% | $4.28B | -27.06% | 0.00% |
| IMVT | 37.05% | $3.10B | -40.69% | 0.00% |
| ABEO | 36.62% | $293.64M | +4.17% | 0.00% |
| ROIV | 36.05% | $7.72B | +0.09% | 0.00% |
| BHVN | 36.01% | $1.42B | -63.43% | 0.00% |
| XENE | 35.92% | $2.47B | -24.95% | 0.00% |
| OCUL | 35.91% | $1.76B | +35.67% | 0.00% |
| DAWN | 35.62% | $688.25M | -55.36% | 0.00% |
| XNCR | 35.48% | $628.44M | -55.20% | 0.00% |
| REPL | 34.75% | $845.64M | +5.89% | 0.00% |
| MYGN | 34.66% | $492.23M | -79.79% | 0.00% |
| RVMD | 34.10% | $7.08B | -15.77% | 0.00% |
| CGON | 33.66% | $2.04B | -24.54% | 0.00% |
| VRTX | 33.61% | $120.40B | -4.07% | 0.00% |
| IDYA | 33.61% | $1.97B | -43.80% | 0.00% |
| VSTS | 33.59% | $809.15M | -50.24% | 1.77% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| TAIL | -26.22% | $94.90M | 0.59% |
| FTSD | -20.24% | $233.24M | 0.25% |
| VIXY | -17.49% | $200.94M | 0.85% |
| VIXM | -16.81% | $22.99M | 0.85% |
| BTAL | -15.96% | $310.24M | 1.43% |
| STOT | -14.82% | $254.22M | 0.45% |
| IVOL | -12.33% | $341.06M | 1.02% |
| KCCA | -11.25% | $109.01M | 0.87% |
| SCHO | -10.29% | $10.92B | 0.03% |
| AGZD | -9.94% | $98.57M | 0.23% |
| SPTS | -9.41% | $5.78B | 0.03% |
| SHYM | -9.08% | $355.87M | 0.35% |
| ULST | -8.38% | $592.71M | 0.2% |
| UTWO | -7.82% | $376.64M | 0.15% |
| BUXX | -7.65% | $312.54M | 0.25% |
| XONE | -7.01% | $629.16M | 0.03% |
| IBTI | -6.99% | $1.07B | 0.07% |
| BSMW | -6.89% | $107.58M | 0.18% |
| CANE | -6.72% | $11.17M | 0.29% |
| TBLL | -6.43% | $2.12B | 0.08% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| GNOM | 48.08% | $45.27M | 0.5% |
| XBI | 47.26% | $5.19B | 0.35% |
| FBT | 43.28% | $1.05B | 0.54% |
| IBB | 43.02% | $5.59B | 0.45% |
| BBH | 40.78% | $345.62M | 0.35% |
| PINK | 39.09% | $132.39M | 0.5% |
| PTH | 35.83% | $97.64M | 0.6% |
| PBE | 35.65% | $233.59M | 0.58% |
| ARKG | 31.60% | $1.10B | 0.75% |
| VHT | 31.48% | $15.49B | 0.09% |
| FHLC | 31.32% | $2.46B | 0.084% |
| IXJ | 30.90% | $3.80B | 0.41% |
| KJUL | 30.03% | $160.44M | 0.79% |
| IYH | 29.82% | $2.76B | 0.39% |
| VBK | 29.75% | $19.43B | 0.07% |
| UJUN | 29.75% | $141.23M | 0.79% |
| TJUL | 29.55% | $156.42M | 0.79% |
| FDLO | 29.49% | $1.23B | 0.16% |
| FTQI | 29.48% | $629.21M | 0.76% |
| BJUN | 29.45% | $185.05M | 0.79% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| NUBD | 0.02% | $397.19M | 0.16% |
| IBMP | -0.03% | $554.05M | 0.18% |
| BNDW | -0.04% | $1.29B | 0.05% |
| USDU | -0.06% | $129.88M | 0.5% |
| SHM | -0.10% | $3.41B | 0.2% |
| GSST | -0.14% | $925.21M | 0.16% |
| SPMB | -0.16% | $6.20B | 0.04% |
| FLMI | 0.20% | $745.34M | 0.3% |
| JPST | 0.25% | $32.02B | 0.18% |
| FMHI | -0.25% | $748.97M | 0.7% |
| MTBA | -0.28% | $1.38B | 0.17% |
| FMB | -0.29% | $1.89B | 0.65% |
| CLIP | 0.29% | $1.51B | 0.07% |
| STIP | 0.30% | $12.73B | 0.03% |
| CARY | 0.33% | $347.36M | 0.8% |
| HYMB | 0.36% | $2.62B | 0.35% |
| LGOV | -0.38% | $651.93M | 0.67% |
| FLGV | 0.39% | $1.02B | 0.09% |
| HYD | -0.41% | $3.31B | 0.32% |
| SHAG | 0.42% | $42.97M | 0.12% |
Current Value
$18.201 Year Return
Current Value
$18.201 Year Return
Finnhub
LOS ANGELES, July 14, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sarepta Therapeutics, Inc. ...
Finnhub
LOS ANGELES, July 14, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Sarepta Therapeutics, Inc. for violations of the federal securities...
Finnhub
Levi & Korsinsky, LLP notifies investors in Sarepta Therapeutics, Inc. of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Sarepta investors who...
Finnhub
NEW YORK, July 14, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Sarepta Therapeutics, Inc. . ...
Finnhub
NEW YORK, July 12, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. . Such investors are advised to contact Danielle Peyton...
Finnhub
NEW YORK, July 12, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor...
